Carol Hall

Title: The Innovative Contributions of Carol Hall

Introduction

Carol Hall is a distinguished inventor based in Raleigh, NC. She has made significant contributions to the field of biochemistry, particularly in the development of peptide inhibitors for HIV reverse transcription. Her innovative work has garnered attention and recognition in the scientific community.

Latest Patents

One of Carol Hall's notable patents is a peptide inhibitor of HIV reverse transcription. This patent discloses peptides that exhibit strong binding to the anticodon stem and loop of human lysine tRNA species, specifically tRNALys3. The starting point for this research was a 15-amino-acid sequence, RVTHHAFLGAHRTVG, which was found to selectively bind to hypermodified tRNALys3. The conformation of the peptide backbone was determined through atomistic simulation of the peptide-ASLLys3 complex. The analysis revealed that two hydrophilic residues, asparagine (ASN) at site 11 and cysteine (CYS) at site 12, contribute to binding specificity through van der Waals energy. Additionally, positively-charged arginines (ARG) at sites 4 and 13 preferentially attract negatively-charged sugar rings and phosphate linkages, enhancing binding affinity.

Career Highlights

Throughout her career, Carol Hall has worked at prominent institutions, including North Carolina State University and The State University of New York. Her research has focused on the intersection of biochemistry and molecular biology, leading to advancements in understanding HIV mechanisms.

Collaborations

Carol has collaborated with notable colleagues, including Xingqing Xiao and Paul F Agris. These partnerships have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Carol Hall's contributions to the field of biochemistry, particularly through her patent on peptide inhibitors, highlight her role as a leading inventor. Her work continues to influence research in HIV treatment and molecular biology.